- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07538063
Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity (MS)
Interactive Educational Methods and Experiences in Nursing Students: A Pilot Study
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Fairfield, Connecticut, United States, 06824
- Fairfield Univesity Nursing School
-
-
New York
-
New York, New York, United States, 10006
- Hunter College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: 1) Adult nursing students ages 18 years and older. 2) All undergraduate nursing students from undergraduate programs at three nursing schools, Hunter College Bellehool of vue School of Nursing, Mount Sinai Phillips School of Nursing, Fairfield University Nursing School.
Exclusion Criteria: 1) Nursing students younger than 18 years old. 2) Nursing students from other nursing schools. 3) Graduate program nursing students.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group - 360-degree educational video
The 360-degree video group included a brain and MS program.
The immersive activity 360-degree group, included a virtual brain and MS program displayed on an interactive computer screen interface.
The 360-degree video allowed learners to manipulate the viewing angle of the video to look around the environment.
A 360-degree video on the brain and the pathophysiology of MS displayed on an e-learning platform enabled the students to self-learn through a procedure simulation with real time feedback.
|
The immersive activity, 360-degree group, included a virtual brain and MS program displayed on an interactive computer screen interface.
The 360-degree video allowed learners to manipulate the viewing angle of the video to look around the environment.
A 360-degree video on the brain and the pathophysiology of MS displayed on an e-learning platform enabled the students to self-learn through a procedure simulation with real time feedback.
|
|
Active Comparator: The slideshow presentation group
The slideshow presentation group viewed 12 slides about the brain and MS with content identical to the content of the 360-degree program.
The educational content consisted of lessons on how the brain and MS interact and interrelate via neurological network.
|
The slideshow presentation included 12 slides about the brain and MS with content identical to the content of the 360-degree program.
The educational content of the PowerPoint slideshow presentation consisted of lessons on how the brain and MS interact and interrelate via neurological network.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Learning effectiveness of immersive 360-degree video versus a slideshow presentation
Time Frame: The outcomes assessed immediately after viewing the educational 360 degrees video or the PowerPoint slideshow presentation.
|
The learning effectiveness was evaluated by two instruments. Outcomes assessed using the MS Knowledge Questionnaire(MSKQ), the MS Magnetic Resonance Imaging Knowledge Questionnaire(MSMRIKQ). The MSMRIKQ is a 20-item questionnaire16 that assesses knowledge about MS and MRI. Face validity was established on all MSMRIKQ items.24 The Kuder-Richardson 20 (KR-20) reliability estimate for the entire scale was 0.58. The split-half reliability with Spearman-Brown correction for the total scale was 0.60. The MSKQ measures basic knowledge of various MS information domains for both clinical and research uses. The Flesch-Kincaid English reading level is 4.8, indicating low reading difficulty. In creating the MSKQ, Giordano et al. (2009) found that the internal consistency was satisfactory (KR-20 = 0.76), and item-total correlations were above 0.30 for 80% of the items. |
The outcomes assessed immediately after viewing the educational 360 degrees video or the PowerPoint slideshow presentation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The emotional experience
Time Frame: The emotional experience was completed immediately after the intervention.
|
The emotional experience was evaluated by the post-lesson experiential questionnaire.
Feelings about each of the respective programs were measured with a set of 17 ad hoc, Likert-style items (scores from 1 to 7, 1=strongly disagree and 7=strongly agree), including a statement on effort and understanding (e.g., "I used a lot of mental effort in the lesson"), a statement on motivation (e.g., "I felt motivated to understand the material"), 4 statements on subject interest for the subject (e.g., "I am interested in learning more about this subject"), engagement with the lesson (e.g., "I felt that the lesson was engaging).26
This questionnaire also included 6 statements about affect during the lesson (e.g.
"I felt happy during the lesson").
Some items were positively worded and others negatively worded; negatively phrased items were reverse-coded prior to analysis to ensure consistent interpretation of composite scores.
The post-intervention also had an open-ended question for comments.
|
The emotional experience was completed immediately after the intervention.
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-0377
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on The immersive 360-degree educational video
-
Universiti Kebangsaan Malaysia Medical CentreCompletedHealthy Adult | Volunteer | Psychological Stress, Anxiety, and Depression Associated With Academic PressureMalaysia
-
Aalborg University HospitalActive, not recruitingBPPV | Benign Paroxysmal Positional VertigoDenmark
-
Seoul National University Bundang HospitalCompletedPostoperative Complications | Anxiety | Emergence Delirium | Preoperative CareKorea, Republic of
-
Universitat de LleidaEnrolling by invitationChronic Nonspecific Low Back PainSpain
-
Karolinska InstitutetRegion StockholmNot yet recruitingOppositional Defiant Disorder | Disruptive Behavior | Conduct Disorders in ChildrenSweden
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Caregiver | Salivary Gland Squamous Cell Carcinoma | Malignant Head and Neck Neoplasm | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Stage... and other conditionsUnited States